|
|
|
Insider
Information: |
Shah Gaurav |
Relationship: |
|
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
728,069 |
|
Indirect Shares
|
406,238 |
|
|
Direct
Value |
$15,522,431 |
|
|
Indirect Value
|
$8,660,994 |
|
|
Total
Shares |
1,134,307 |
|
|
Total
Value |
$24,183,425 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
5
|
Stock
price went up :
|
1
|
3
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
1.0
|
1.5
|
Percentage
Gain/Loss : |
5.2%
|
50.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Rocket Pharmaceuticals |
RCKT |
|
2024-05-16 |
728,069 |
2024-05-16 |
406,238 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RCKT |
Rocket Pharmaceuticals |
CEO |
|
2024-05-16 |
4 |
S |
$23.35 |
$228,597 |
D/D |
(9,790) |
728,069 |
0 |
% |
|
RCKT |
Rocket Pharmaceuticals |
CEO |
|
2024-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,662 |
646,134 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
CEO |
|
2024-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
66,577 |
621,339 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
CEO |
|
2024-02-16 |
4 |
S |
$29.84 |
$604,876 |
D/D |
(20,272) |
554,762 |
0 |
% |
|
RCKT |
Rocket Pharmaceuticals |
CEO |
|
2024-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
46,828 |
575,034 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
CEO |
|
2023-11-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,979 |
532,833 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
CEO |
|
2023-08-17 |
4 |
S |
$15.47 |
$73,750 |
D/D |
(4,767) |
524,854 |
0 |
% |
|
RCKT |
Rocket Pharmaceuticals |
CEO |
|
2023-08-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,979 |
529,621 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
CEO |
|
2023-05-17 |
4 |
S |
$21.38 |
$88,108 |
D/D |
(4,122) |
521,642 |
0 |
% |
|
RCKT |
Rocket Pharmaceuticals |
CEO |
|
2023-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,979 |
525,764 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
CEO |
|
2023-02-17 |
4 |
S |
$19.06 |
$232,418 |
D/D |
(12,194) |
536,885 |
0 |
% |
|
RCKT |
Rocket Pharmaceuticals |
CEO |
|
2023-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
67,785 |
737,859 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
CEO |
|
2023-02-14 |
4/A |
OE |
$0.00 |
$0 |
D/D |
31,440 |
549,079 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
CEO |
|
2022-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
23,940 |
670,074 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
CEO |
|
2022-02-07 |
4 |
B |
$17.34 |
$381,513 |
D/D |
22,000 |
517,639 |
0.01 |
% |
|
RCKT |
Rocket Pharmaceuticals |
CEO |
|
2021-04-01 |
4 |
D |
$45.21 |
$1,032,554 |
D/D |
(22,266) |
495,639 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
CEO |
|
2021-03-31 |
4 |
D |
$45.94 |
$344,235 |
D/D |
(7,493) |
517,905 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
CEO |
|
2021-03-31 |
4 |
D |
$44.24 |
$3,887,647 |
D/D |
(87,353) |
525,398 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
CEO |
|
2021-03-31 |
4 |
OE |
$1.69 |
$128,237 |
D/D |
75,880 |
612,751 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
CEO |
|
2021-03-30 |
4 |
D |
$41.80 |
$3,720,492 |
D/D |
(85,888) |
536,871 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
President & CEO |
|
2020-03-24 |
4 |
OE |
$0.43 |
$39,098 |
D/D |
90,925 |
1,061,642 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
President & CEO |
|
2020-03-24 |
4 |
D |
$13.78 |
$449,848 |
D/D |
(32,645) |
1,028,997 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
President & CEO |
|
2020-02-25 |
4 |
D |
$20.15 |
$125,595 |
D/D |
(6,233) |
970,717 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
President & CEO |
|
2020-02-25 |
4 |
OE |
$0.43 |
$125,628 |
D/D |
290,000 |
976,950 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
See Remarks |
|
2019-03-05 |
4 |
AS |
$16.90 |
$422,500 |
D/D |
(25,000) |
686,950 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|